A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Promontory Therapeutics Inc.
Promontory Therapeutics Inc.
Catalysis SL
NanOlogy, LLC
Celldex Therapeutics
NanOlogy, LLC
Novartis
Dendreon
Pierre Fabre Medicament
Eli Lilly and Company